What is the recommended treatment for esophageal varices?

Treatment of Esophageal Varices

The treatment of esophageal varices depends on whether you are preventing a first bleed (primary prophylaxis), managing acute hemorrhage, or preventing rebleeding (secondary prophylaxis), with non-selective beta-blockers or endoscopic variceal ligation for prevention, and immediate vasoactive drugs plus endoscopic band ligation for acute bleeding. 1

Primary Prophylaxis: Preventing the First Variceal Hemorrhage

For Medium or Large Varices

Either non-selective beta-blockers (NSBBs) or endoscopic variceal ligation (EVL) should be used for primary prophylaxis in patients with medium or large esophageal varices. 1

• Propranolol 20-40 mg orally twice daily should be titrated every 2-3 days to achieve a resting heart rate of 55-60 beats per minute, with a maximum dose of 320 mg/day in patients without ascites or 160 mg/day in those with ascites 1

• Nadolol 20-40 mg orally once daily can be used as an alternative, titrated to the same heart rate goal, with maximum doses of 160 mg/day (no ascites) or 80 mg/day (with ascites) 1

• Carvedilol 6.25 mg once daily should be started, then increased after 3 days to 6.25 mg twice daily, with a maximum dose of 12.5 mg/day; systolic blood pressure must remain ≥90 mm Hg 1, 2

• EVL can be performed every 2-8 weeks until variceal eradication is achieved, with follow-up endoscopy 3-6 months after eradication, then every 6-12 months 1

• Combination therapy with NSBBs plus EVL is NOT recommended for primary prophylaxis, as current data do not support added benefit 1

For Small Varices at High Risk

• NSBBs should be used in patients with small varices who have red wale marks or are in a decompensated state 1

• Patients with small varices without high-risk features can be monitored with repeat endoscopy in 1-2 years 1

Acute Variceal Hemorrhage: Emergency Management

Vasoactive pharmacological therapy must be initiated immediately when variceal bleeding is suspected, even before endoscopic confirmation. 1, 3

Immediate Pharmacological Interventions

• Terlipressin is the preferred vasoactive agent due to its longer half-life and fewer adverse effects 2

• Octreotide or somatostatin are equally effective alternatives with favorable safety profiles 1, 2

• Vasoactive therapy should be continued for 3-5 days after diagnosis is confirmed 1, 3

• Ceftriaxone 1 g IV daily for up to 7 days is the first-line antibiotic prophylaxis in patients with advanced cirrhosis or in centers with quinolone-resistant organisms 1, 3

• Norfloxacin 400 mg orally twice daily is an alternative antibiotic in less severe cases 1

• Erythromycin 250 mg IV should be given 30-120 minutes before endoscopy to improve visualization by promoting gastric emptying 3

Resuscitation Parameters

• Maintain hemoglobin at 7-8 g/dL with a restrictive transfusion strategy to avoid increasing portal pressure 1, 3

• Volume resuscitation should restore hemodynamic stability without over-transfusion 1

Endoscopic Management

• Endoscopy should be performed within 12 hours after hemodynamic stabilization 1, 3

• Endoscopic variceal ligation (EVL) is the endoscopic method of choice for acute esophageal variceal bleeding 1, 4, 3

• Sclerotherapy can be used if EVL is technically not feasible, though it is inferior to EVL 1

• Pantoprazole 40 mg IV followed by 40 mg oral daily for 9 days reduces post-EVL ulcer size and may decrease post-procedure bleeding 1

Rescue Therapy for Uncontrolled Bleeding

• Transjugular intrahepatic portosystemic shunt (TIPS) is indicated when bleeding cannot be controlled or recurs despite combined pharmacological and endoscopic therapy 1

• Pre-emptive TIPS within 72 hours (preferably within 24 hours) should be considered in high-risk patients: Child-Pugh C ≤13 or Child-Pugh B >7 with active bleeding at endoscopy despite vasoactive agents 3

• Balloon tamponade should be used only as a temporizing measure for maximum 24 hours in patients with uncontrollable bleeding while awaiting definitive therapy 1

Secondary Prophylaxis: Preventing Rebleeding

Combination therapy with NSBBs plus endoscopic variceal ligation is the optimal strategy for preventing rebleeding after an acute variceal hemorrhage episode. 1, 2, 3

• Combination therapy is superior to either NSBBs or EVL alone in reducing rebleeding rates 2, 3

• EVL sessions should be repeated every 1-4 weeks until variceal eradication 3, 5

• Propranolol or carvedilol should be continued long-term in combination with EVL 3

• The median rebleeding rate with EVL alone is approximately 32%, which is reduced with combination therapy 1

Special Considerations for Gastric Varices

• Endoscopic cyanoacrylate injection is the treatment of choice for acute gastric variceal bleeding (GOV2, IGV1) 1, 3

• For GOV1 varices (extending along lesser curvature), either cyanoacrylate injection or EVL can be used 3

• Cyanoacrylate achieves better control of gastric variceal bleeding with lower rebleeding rates (23% vs 47%) compared to EVL 1

Critical Safety Parameters and Contraindications

• NSBBs should be temporarily withheld during acute hypotensive bleeding when systolic blood pressure is <90 mm Hg 2

• Systolic blood pressure must not decrease below 90 mm Hg during NSBB therapy 1

• TIPS is NOT recommended for prevention of first variceal hemorrhage 1

• Patients on NSBBs for primary prophylaxis do not require serial surveillance endoscopy 1